Patient Guide: A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 37 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT05744921
Status: 🟢 Enrolling Now
Condition: Paroxysmal Nocturnal Hemoglobinuria
Phase: PHASE3

Find a Study Location Near You

This study is available at 37 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Toronto, Ontario
  • • Budapest,
  • • Kochi, Kerala
  • • And 34 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works - Join Clinical Trial NCTNCT05744921

How to Join This Clinical Trial - NCTNCT05744921

Learn how to participate in this PHASE3 trial studying an investigational therapy for Paroxysmal Nocturnal Hemoglobinuria. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Paroxysmal Nocturnal Hemoglobinuria. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Paroxysmal Nocturnal Hemoglobinuria
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05744921 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 37 locations. Find a study site near you:

Clinical Research Site

Toronto, Ontario M5G 2C4 - Canada

Status: RECRUITING

Clinical Research Site

Budapest, 1083 - Hungary

Status: RECRUITING

Clinical Research Site

Kochi, Kerala 682041 - India

Status: RECRUITING

Clinical Research Site

New Delhi, National Capital Territory of Delhi 110085 - India

Status: RECRUITING

Clinical Research Site

Jaipur, 302017 - India

Status: RECRUITING

Clinical Research Site

Florence, Firenze 50139 - Italy

Status: RECRUITING

Clinical Research Site

Torino, 10126 - Italy

Status: RECRUITING

Clinical Research Site

Tsukuba, Ibaraki 305-8576 - Japan

Status: RECRUITING

Clinical Research Site

Amman, 11942 - Jordan

Status: RECRUITING

Clinical Research Site

Kuantan, Pahang 25200 - Malaysia

Status: RECRUITING

And 27 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Paroxysmal Nocturnal Hemoglobinuria:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation